US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) for a Phase II trial of Arakoda (tafenoquine) for treating chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback